Lakeview Health Care & Rehabilitation Center | |
1450 Ashley Road, Boonville, Missouri 65233 | |
(660) 882-7007 | |
Name | Lakeview Health Care & Rehabilitation Center |
---|---|
Location | 1450 Ashley Road, Boonville, Missouri |
Certified By | Medicare and Medicaid |
No. of Certified Beds | 59 |
Occupancy Rate | 81.19% |
Medicare ID (CCN) | 265522 |
Legal Business Name | Boonville #1 Inc |
Ownership Type | For Profit - Individual |
NPI Number | 1295767275 |
Organization Name | BOONVILLE NO 1 INC |
Doing Business As | LAKEVIEW HEALTH CARE & REHABILITATION CENTER |
Address | 1450 W Ashley Rd, Boonville, MO 65233 |
Phone Number | 660-882-7007 |
News Archive
Some of Chicago's poorest neighborhoods are expected to see the greatest demand for additional primary care doctors in 2014, as the Affordable Care Act boosts the number of newly insured patients seeking medical services, a new study has found.
The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.
NeuroSigma, Inc., a California-based medical device company, today announced the launch of www.monarch-etns.com, its dedicated website for the Monarch™ eTNSTM System.
In an interview with Foreign Policy's blog "The Cable," USAID Administrator Rajiv Shah said a Republican Study Committee (RSC) proposal to trim the U.S. foreign aid budget, in addition to other non-defense programs, could weaken U.S. national security.
ChemGenex Pharmaceuticals Limited announced that positive safety findings from a combined analysis of two clinical trials for its lead product candidate, OMAPRO™ (omacetaxine mepesuccinate), were presented today during a poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 2 days ago
Ratings from Surveys (Inspections): | |
Ratings from Quality Measures: | |
Ratings from Staffing Data: | |
Overall Rating: |
---|
News Archive
Some of Chicago's poorest neighborhoods are expected to see the greatest demand for additional primary care doctors in 2014, as the Affordable Care Act boosts the number of newly insured patients seeking medical services, a new study has found.
The National Institutes of Health has awarded Tulane University more than $12 million to test a promising drug treatment against Lassa fever and develop a vaccine against the deadly disease endemic in parts of West Africa.
NeuroSigma, Inc., a California-based medical device company, today announced the launch of www.monarch-etns.com, its dedicated website for the Monarch™ eTNSTM System.
In an interview with Foreign Policy's blog "The Cable," USAID Administrator Rajiv Shah said a Republican Study Committee (RSC) proposal to trim the U.S. foreign aid budget, in addition to other non-defense programs, could weaken U.S. national security.
ChemGenex Pharmaceuticals Limited announced that positive safety findings from a combined analysis of two clinical trials for its lead product candidate, OMAPRO™ (omacetaxine mepesuccinate), were presented today during a poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 2 days ago
Number of Facility Reported Incidents | 0 |
Number of Substantiated Complaints | 0 |
Number of Fines | 1 |
Total Amount of Fines in Dollars | $99340 |
Number of Payment Denials | 0 |
Total Number of Penalties | 1 |
Experience Measure | Provider | National Avg. |
---|---|---|
Percentage of long-stay residents whose need for help with daily activities has increased | 17.71 | 14.46 |
Percentage of long-stay residents who lose too much weight | 7.23 | 5.51 |
Percentage of low risk long-stay residents who lose control of their bowels or bladder | 21.98 | 48.41 |
Percentage of long-stay residents with a catheter inserted and left in their bladder | 3.55 | 1.79 |
Percentage of long-stay residents with a urinary tract infection | 2.92 | 2.65 |
Percentage of long-stay residents who have depressive symptoms | 21.59 | 5.05 |
Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
Percentage of long-stay residents experiencing one or more falls with major injury | 0.5 | 3.36 |
Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 93.87 |
Percentage of long-stay residents who received an antipsychotic medication | 49.38 | 14.2 |
Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 100 | 83.88 |